Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gallagher

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Contemporary Clinical Trials|June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trialDavid Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 28, 2023
Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International SurveyLawrence Ledoux-Hutchinson, Ron Wald, Manu L N G Malbrain, et al.
The New England Journal of Medicine|November 14, 2017
Outcomes after Angiography with Sodium Bicarbonate and AcetylcysteineSteven D Weisbord, Martin Gallagher, Hani Jneid, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 11, 2013
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trialSteven D Weisbord, Martin Gallagher, James Kaufman, et al.
Canadian Journal of Kidney Health and Disease|December 15, 2025
Proactive Prescription-Based Fluid Management Versus Usual Care in Critically Ill Patients on Kidney Replacement Therapy (Probe-Fluid): A Pilot Clinical Trial ProtocolAlicia Shen, Josée Bouchard, Javier A Neyra, et al.
Critical Care (London, England)|March 22, 2024
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trialsMatthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, et al.
Diabetes, Obesity & Metabolism|July 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care datasetHannah Wallace, James Wick, Brendon L Neuen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 27, 2022
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational studyMin Jun, Anish Scaria, Jason Andrade, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaAllison Tong, Sally Crowe, Shingisai Chando, et al.
Kidney360|April 9, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based StudyDickson Lam, Anish Scaria, Jason Andrade, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Contemporary Clinical Trials|June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trialDavid Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 28, 2023
Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International SurveyLawrence Ledoux-Hutchinson, Ron Wald, Manu L N G Malbrain, et al.
The New England Journal of Medicine|November 14, 2017
Outcomes after Angiography with Sodium Bicarbonate and AcetylcysteineSteven D Weisbord, Martin Gallagher, Hani Jneid, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 11, 2013
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trialSteven D Weisbord, Martin Gallagher, James Kaufman, et al.
Canadian Journal of Kidney Health and Disease|December 15, 2025
Proactive Prescription-Based Fluid Management Versus Usual Care in Critically Ill Patients on Kidney Replacement Therapy (Probe-Fluid): A Pilot Clinical Trial ProtocolAlicia Shen, Josée Bouchard, Javier A Neyra, et al.
Critical Care (London, England)|March 22, 2024
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trialsMatthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, et al.
Diabetes, Obesity & Metabolism|July 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care datasetHannah Wallace, James Wick, Brendon L Neuen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 27, 2022
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational studyMin Jun, Anish Scaria, Jason Andrade, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaAllison Tong, Sally Crowe, Shingisai Chando, et al.
Kidney360|April 9, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based StudyDickson Lam, Anish Scaria, Jason Andrade, et al.
Pageof 19